BEHAVIORAL · Unmapped registry intervention
Focus Group
Find medicine records ·
Find other trials using this name
Clinical trial
A Text-based Intervention in Improving Adherence to Hormone Therapy in Patients With Stage I-III Hormone Receptor Positive Breast Cancer
NCT04086875
Study summary
ClinicalTrials.govA Text-based Intervention in Improving Adherence to Hormone Therapy in Patients With Stage I-III Hormone Receptor Positive Breast Cancer
Design: INTERVENTIONAL · Status: UNKNOWN · Phase: NA
Loading study purpose, treatment groups and outcomes…
View the complete registry record, eligibility and contacts at ClinicalTrials.gov
Drugs and interventions used in this trial
4 registeredThese interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.
OTHER · Unmapped registry intervention
Text Message
Find medicine records ·
Find other trials using this name
OTHER · Unmapped registry intervention
Best Practice
Find medicine records ·
Find other trials using this name
OTHER · Unmapped registry intervention
Questionnaire Administration
Find medicine records ·
Find other trials using this name
No matching interventions in this trial.
Advertisement
Conditions
Anatomic Stage I Breast Cancer AJCC v8unresolved
Anatomic Stage IIA Breast Cancer AJCC v8unresolved
Anatomic Stage IA Breast Cancer AJCC v8unresolved
Anatomic Stage II Breast Cancer AJCC v8unresolved
Anatomic Stage III Breast Cancer AJCC v8unresolved
Anatomic Stage IIB Breast Cancer AJCC v8unresolved
Estrogen Receptor Positive Tumorunresolved
Progesterone Receptor Positive Tumorunresolved
Prognostic Stage I Breast Cancer AJCC v8unresolved
Interventions
Sponsors & collaborators
Thomas Jefferson Universitylead sponsor
National Cancer Institute (NCI)collaborator
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT04086875 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.